日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Estimating influenza A subtype ratios among critical care admissions in England

估算英格兰重症监护入院患者中甲型流感亚型比例

Wolmuth-Gordon, Hannah Sophie; Elgohari, Suzanne; Dabrera, Gavin; Green, Rebecca E

Surveillance of International Travel of COVID‐19 Cases (SuITCases) in England

英国对新冠肺炎病例国际旅行(SuITCases)的监测

Abbey, Ashkan M; Besirli, Cagri G; Musch, David C; Andrews, Chris A; Capone, Antonio Jr; Drenser, Kimberly A; Wallace, David K; Ostmo, Susan; Chiang, Michael; Lee, Paul P; Trese, Michael T; Sinnathamby, Mary A; Twohig, Katherine; Abdul Aziz, Nurin; Halford, Florence; Zaidi, Asad; Harman, Katie; Thelwall, Simon; Allen, Alex; Dabrera, Gavin

Post-Mortem Community Surveillance of COVID-19: Implementation and Evaluation of a Pilot System in the Funeral Sector in England, UK, January 2021 to February 2022

新冠肺炎死后社区监测:英国英格兰殡葬业试点系统的实施与评估(2021年1月至2022年2月)

Emmett, Hannah E; Hall, Jennifer; Webster, Harriet H; Izzard, Abigail; Singanayagam, Anika; Zambon, Maria; Dabrera, Gavin

"I definitely cannot afford to be feeling poorly if there's no need to be": a qualitative evaluation of antiviral uptake following suspected occupational exposure to avian influenza

“如果没必要生病,我绝对不能承受这种痛苦”:对疑似职业性接触禽流感后抗病毒药物使用情况的定性评估

Pae, Riinu; Findlater, Lucy; Amlôt, Richard; Capelastegui, Fernando; Dabrera, Gavin; Humphreys, Clare; Kumbang, Jharna; Oliver, Isabel

Development of the ECHOES national dataset: a resource for monitoring post-acute and long-term COVID-19 health outcomes in England

ECHOES国家数据集的开发:用于监测英格兰COVID-19急性后期和长期健康结果的资源

Allen, Hester; Hassell, Katie; Rawlinson, Christopher; Pullen, Owen; Campbell, Colin; Jödicke, Annika M; Català, Martí; Prats-Uribe, Albert; Dabrera, Gavin; Prieto-Alhambra, Daniel; Campos-Matos, Ines

Severity of COVID-19 sub-lineages XBB/XBB 1.5/XBB1.16, EG.5.1. and JN.1. in England

英格兰 COVID-19 亚系 XBB/XBB 1.5/XBB1.16、EG.5.1 和 JN.1 的严重程度

Quinot, Catherine; Kirsebom, Freja; Andrews, Nick; Stowe, Julia; Ramsay, Mary; Dabrera, Gavin; Kall, Meaghan; Bernal, Jamie Lopez; Allen, Alex

Effectiveness of the Sanofi/GSK (VidPrevtyn Beta) and Pfizer-BioNTech (Comirnaty Original/Omicron BA.4-5) bivalent vaccines against hospitalisation in England

赛诺菲/葛兰素史克(VidPrevtyn Beta)和辉瑞-BioNTech(Comirnaty Original/Omicron BA.4-5)二价疫苗在英格兰预防住院的有效性

Kirsebom, Freja Cordelia Møller; Andrews, Nick; Stowe, Julia; Dabrera, Gavin; Ramsay, Mary; Lopez Bernal, Jamie

Setting thresholds to determine COVID-19 activity levels using the mean standard deviation (MSD) method, England, 2022-2024

利用均值标准差 (MSD) 方法设定阈值以确定英格兰 2022-2024 年 COVID-19 活动水平

Sinnathamby, Mary A; Bourouphael, Tania; Boateng, Jacob; Collonnaz, Magali; Quinot, Catherine; Aziz, Nurin Abdul; Elgohari, Suzanne; Green, Rebecca E; Dabrera, Gavin; Lopez-Bernal, Jamie; Allen, Alex

Comparison of two COVID-19 mortality measures used during the pandemic response in England

比较英格兰在新冠疫情应对期间使用的两种新冠肺炎死亡率衡量指标

Seghezzo, Giulia; Allen, Hester; Griffiths, Clare; Pooley, Justine; Beardsmore, Liam; Caul, Sarah; Glickman, Myer; Clare, Tom; Dabrera, Gavin; Kall, Meaghan

Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial

伊沙康唑治疗儿童侵袭性真菌病的安全性、疗效和药代动力学:一项非对照 II 期试验

Segers, Heidi; Deville, Jaime G; Muller, William J; Manzanares, Angela; Desai, Amit; Neely, Michael; Bordon, Victoria; Hanisch, Benjamin; Lassaletta, Alvaro; Fisher, Brian T; Autmizguine, Julie; Groll, Andreas H; Sinnar, Shamim; Croos-Dabrera, Rodney; Engelhardt, Marc; Jones, Mark; Kovanda, Laura L; Arrieta, Antonio C